---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-125282"
form_type: "8-K"
ticker: "INMB"
cik: "0001711754"
company_name: "Inmune Bio, Inc."
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:16:20.308086+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# INmune Bio amends 1.35M April 2024 warrants; exercise price cut to $1.95, term extended to June 2026

## Summary
- Exercise price of 1,348,315 outstanding April 2024 warrants reduced to $1.95 per share.
- Warrant term extended to expire on June 30, 2026 (from earlier conditional triggers).
- Holders paid $0.05 per warrant ($67,416 total) as amendment consideration.
- Warrants were originally issued in April 2024 offerings (April 24 & 29, 2024).
- Amendment effective upon receipt of signed amendment and full consideration.

## SEC filing metadata
- accession: 0001213900-25-125282
- form_type: 8-K
- ticker: INMB
- cik: 0001711754
- company_name: Inmune Bio, Inc.
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/0001213900-25-125282-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/ea0270723-8k_inmune.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-125282
- JSON: https://secwatch.observer/filing/0001213900-25-125282.json
- Plain text: https://secwatch.observer/filing/0001213900-25-125282.txt

## Key facts
- Material Agreements
  Inmune Bio, Inc. amended Warrant Amendment with certain holders of warrants previously issued by the Company valued at $0.05 per April 2024 Warrant, for aggregate proceeds of $67,416 (effective 2025-12-22).
  - Action: amendment
  - Counterparty: certain holders of warrants previously issued by the Company
  - Value: $0.05 per April 2024 Warrant, for aggregate proceeds of $67,416
  - Effective: 2025-12-22
  source text: On December 22, 2025, INmune Bio Inc. (the “Company”) entered into an amendment (the “Warrant Amendment”) with certain holders of warrants previously issued by the Company in its April 2024 offerings
  evidence_url: https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/0001213900-25-125282-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.